APA (7th ed.) Citation

B, L., C, L., HM, M., SY, J., SJ, J., & YA, S. (2023). Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models. Cells, 12(24), . https://doi.org/10.3390/cells12242859

Chicago Style (17th ed.) Citation

B, Lee, Lee C, Moon HM, Jo SY, Jang SJ, and Suh YA. "Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models." Cells 12, no. 24 (2023). https://doi.org/10.3390/cells12242859.

MLA (9th ed.) Citation

B, Lee, et al. "Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models." Cells, vol. 12, no. 24, 2023, https://doi.org/10.3390/cells12242859.